Our Medicines
The product information on this webpage is not intended for an audience residing in any particular jurisdiction.
Our approved or authorized medicines
At Regeneron, our goal is to address serious medical conditions across multiple and diverse therapeutic areas. Our approved and authorized medicines are only the beginning of our long-term commitment to solve the human body’s most complex mysteries. Almost 100% of our product candidates were invented and developed in-house, and Regeneron-invented medicines are available in over 100 countries worldwide.
8
European Medicines Agency authorized medicines
7
medicines approved by Japan's Pharmaceuticals and Medical Devices Agency
Research areas and investigational pipeline
In 2023, we invested $4.4 billion into R&D, supporting research in areas including allergic and inflammatory diseases, cardiovascular and metabolic diseases, neuroscience, oncology and hematology, ophthalmology, rare diseases and other therapeutic areas.
Our broad pipeline features 30+ programs in clinical development, 18 of which are late-stage programs, and clinical trials in ~60 countries worldwide.
Explore our clinical trials
The discoveries never stop as we work to help people with serious diseases. Clinical trials allow us to carefully test and collect data about investigational products before they can be approved for use.
Health equity & access to our medicines
We are motivated to deliver new medicines for people in need – and we want to make sure people can access and afford those medicines regardless of their background or geography. We are committed to developing pricing approaches that facilitate patient access and foster medical innovation through engagement with our stakeholders.
Making our medicines
Grounded in excellence and driven to continuously improve, our industry-leading Industrial Operations & Product Supply team is responsible for the production of our many medicines.
Medical Inquiries
Healthcare professionals, patients or caregivers may report an adverse event or report a product complaint for a Regeneron product to our Global Medical Information Department. In addition, healthcare professionals may request specific product information. Please call our global phone number +353 61 533 400 or email Medical.information_Global@regeneron.com. For country-specific contact information, refer to our Global Medical Information contact list.
With our commitment to patient safety, if you are reporting an adverse event or product complaint, please report as much relevant information as possible which may include product indication, lot number and return availability.